Declining Mortality in Patients With Acute Respiratory Distress Syndrome: An Analysis of the Acute Respiratory Distress Syndrome Network Trials

Objectives: There has been multiple advances in the management of acute respiratory distress syndrome, but the temporal trends in acute respiratory distress syndrome–related mortality are not well known. This study aimed to investigate the trends in mortality in acute respiratory distress syndrome patients over time and to explore the roles of daily fluid balance and ventilation variables in those patients. Design: Secondary analysis of randomized controlled trials conducted by the Acute Respiratory Distress Syndrome Network from 1996 to 2013. Setting: Multicenter study involving Acute Respiratory Distress Syndrome Network trials. Patients: Patients with acute respiratory distress syndrome. Interventions: None. Measures and Main Results: Individual patient data from 5,159 acute respiratory distress syndrome patients (excluding the Late Steroid Rescue Study trial) were enrolled in this study. The crude mortality rate decreased from 35.4% (95% CI, 29.9–40.8%) in 1996 to 28.3% (95% CI, 22.0–34.7%) in 2013. By adjusting for the baseline Acute Physiology and Chronic Health Evaluation III, age, ICU type, and admission resource, patients enrolled from 2005 to 2010 (odds ratio, 0.61; 95% CI, 0.50–0.74) and those enrolled after 2010 (odds ratio, 0.73; 95% CI, 0.58–0.92) were associated with lower risk of death as compared to those enrolled before 2000. The effect of year on mortality decline disappeared after adjustment for daily fluid balance, positive end-expiratory pressure, tidal volume, and plateau pressure. There were significant trends of declines in daily fluid balance, tidal volume, and plateau pressure and an increase in positive end-expiratory pressure over the 17 years. Conclusions: Our study shows an improvement in the acute respiratory distress syndrome-related mortality rate in the critically ill patients enrolled in the Acute Respiratory Distress Syndrome Network trials. The effect was probably mediated via decreased tidal volume, plateau pressure, and daily fluid balance and increased positive end-expiratory pressure.

[1]  Diane L. Seger,et al.  A value set for documenting adverse reactions in electronic health records , 2018, J. Am. Medical Informatics Assoc..

[2]  Zhongheng Zhang,et al.  Comparing baseline characteristics between groups: an introduction to the CBCgrps package. , 2017, Annals of translational medicine.

[3]  M. Amato,et al.  Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2017, JAMA.

[4]  Roberto Fumagalli,et al.  Definition and epidemiology of acute respiratory distress syndrome. , 2017, Annals of translational medicine.

[5]  S. Kalkman,et al.  Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences. , 2017, Journal of clinical epidemiology.

[6]  J. Marshall,et al.  Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis , 2017, Intensive Care Medicine.

[7]  D. Chiumello,et al.  Current Concepts of ARDS: A Narrative Review , 2016, International journal of molecular sciences.

[8]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[9]  M. Wilhelm,et al.  External validation of scores proposed for estimation of survival probability of patients with severe adult respiratory distress syndrome undergoing extracorporeal membrane oxygenation therapy: a retrospective study , 2015, Critical Care.

[10]  Russell R. Miller,et al.  Fluid Management With a Simplified Conservative Protocol for the Acute Respiratory Distress Syndrome* , 2015, Critical care medicine.

[11]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[12]  J. Fine,et al.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. , 2013, Journal of clinical epidemiology.

[13]  G. Sigurdsson,et al.  Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years , 2013, Acta anaesthesiologica Scandinavica.

[14]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[15]  T. Rice,et al.  Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial , 2012 .

[16]  T. Rice,et al.  Supplementation in Acute Lung Injury—Reply , 2012 .

[17]  T. Rice,et al.  Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. , 2011, JAMA.

[18]  Lung,et al.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[19]  M. Malinchoc,et al.  Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. , 2011, American journal of respiratory and critical care medicine.

[20]  Matthias Briel,et al.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. , 2010, JAMA.

[21]  G. Martin,et al.  Recent trends in acute lung injury mortality: 1996–2005* , 2009, Critical care medicine.

[22]  George Tomlinson,et al.  Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. , 2009, American journal of respiratory and critical care medicine.

[23]  R. Hayward,et al.  Beyond the Randomized Clinical Trial the Role of Effectiveness Studies in Evaluating Cardiovascular Therapies the Achilles' Heel of Rcts Key Issues in Outcomes Research , 2022 .

[24]  B. Thompson,et al.  Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. , 2008, American journal of respiratory and critical care medicine.

[25]  D. McAuley,et al.  Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management , 2008, Critical care.

[26]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[27]  R. Hyzy,et al.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. , 2006, The New England journal of medicine.

[28]  Marek Ancukiewicz,et al.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. , 2009, The New England journal of medicine.

[29]  J. Bion,et al.  Epidemiology and outcome of acute lung injury in European intensive care units , 2004, Intensive Care Medicine.

[30]  J. Bion,et al.  Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. , 2004, Intensive care medicine.

[31]  Arthur S Slutsky,et al.  Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome , 2002, Critical care medicine.

[32]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[33]  Kristian Antonsen,et al.  Incidence and Mortality after Acute Respiratory Failure and Acute Respiratory Distress Syndrome in Sweden, Denmark, and Iceland , 1999 .

[34]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[35]  K Antonsen,et al.  Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. , 1999, American journal of respiratory and critical care medicine.

[36]  K. Burgess,et al.  Acute respiratory distress syndrome in a community hospital ICU , 1997, Intensive Care Medicine.

[37]  W. Cleveland.  LOWESS: A Program for Smoothing Scatterplots by Robust Locally Weighted Regression , 1981 .